2 days ago · The latest price target for Applied Therapeutics ( NASDAQ: APLT) was reported by Baird on Tuesday, April 25, 2023. The analyst firm set a price target for 14.00 expecting APLT to rise to within 12 ... shoshana Shendelman APLT stock SEC Form 4 insiders trading. shoshana has made over 11 trades of the Applied Therapeutics stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 3,968 units of APLT stock worth $7,817 on 30 November 2023.. The largest trade he's ever made was exercising 125,000 units of …Applied Therapeutics, Inc. (APLT) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. 2W 10W 9M. 5.63 +0.03 (+0.54%) As of 09:34AM EST. Market open. 1d. AT-007 for Galactosemia. AT-007 is a once-daily oral compound that inhibits the enzyme Aldose Reductase. Aldose Reductase plays a crucial role in the pathogenesis of Galactosemia. Galactosemia is a rare, slowly progressing metabolic disease caused by a genetic inability to break down the sugar galactose. Aldose Reductase converts …Les Funtleyder is a healthcare portfolio manager at E Squared Capital Management and currently serves as the Chief Financial Officer for Applied Therapeutics. He was formerly the director of strategic investments for Opko Health and held roles as strategist and portfolio manager for Miller Tabak Health Transformation Fund, Provident Advisors, and …Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY. NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated ...What is the Applied Therapeutics stock forecast? · Applied Therapeutics stock prediction for 1 year from now: $ 33.91 (505.48%) · Applied Therapeutics stock ...The PE Ratio as of February 2024 (TTM) for Applied Therapeutics, Inc. ( APLT) is -4.10. According to Applied Therapeutics, Inc. ’s latest financial reports and current stock price. The company's current PE Ratio is -4.10. This represents a change of 253.73% compared to the average of -1.16 of the last 4 quarters.NEW YORK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced it has submitted a New Drug Application (NDA) to the U.S. Food and …shoshana Shendelman APLT stock SEC Form 4 insiders trading. shoshana has made over 11 trades of the Applied Therapeutics stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 3,968 units of APLT stock worth $7,817 on 30 November 2023.. The largest trade he's ever made was exercising 125,000 units of …Applied Therapeutics (NASDAQ:APLT) stock jumped 10% in late morning trading Wednesday after the company said it has submitted applications for FDA and EU approval of its drug govorestat, also ...Applied Therapeutics (APLT) Stock Price, News & Analysis. $5.38. +1.63 (+43.47%) (As of 04:26 PM ET) Compare. Today's Range. $3.73. . $5.83. 50-Day …APLT - Applied Therapeutics, Inc. (NasdaqGM) - Share Price and News.Applied Therapeutics Inc. Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY. Results of Applied Therapeutics' Phase 3 INSPIRE trial for oral govorestat (AT-007). Govorestat demonstrates significant sorbitol reduction, improving mobility and overall well-being in SORD ...NEW YORK, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced it has completed its public offering of 3,152,712 …NEW YORK, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates ...The current Applied Therapeutics [ APLT] share price is $5.40. The Score for APLT is 82, which is 64% above its historic median score of 50, and infers lower risk than normal. APLT is currently trading in the 80-90% percentile range relative to …Feb 16, 2024 · Applied Therapeutics stock rises on EMA orphan drug status for metabolic disorder drug AT-007 SA News Fri, Jun. 03, 2022 1 Comment Applied Therapeutics GAAP EPS of -$0.88 Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest...Feb 15, 2024 · Currently, Applied Therapeutics stock is climbing 16.04 percent, to $3.11 over the previous close of $2.68 on a volume of 3,752,156. It had traded between $0.757 and $4.42 for the past 52 weeks on ... View the latest Applied Therapeutics Inc. (APLT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Historical daily share price chart and data for Applied Therapeutics since 2019 adjusted for splits and dividends. The latest closing stock price for Applied Therapeutics as of January 12, 2024 is 2.50.. The all-time high Applied Therapeutics stock closing price was 55.47 on February 05, 2020.; The Applied Therapeutics 52-week high stock price is 4.42, which …Future criteria checks 2/6. Applied Therapeutics is forecast to grow earnings and revenue by 14% and 79.2% per annum respectively. EPS is expected to grow by 22.3% per annum. Return on equity is forecast to be -229.5% in 3 years.NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it plans to make a public offering of shares of …Shendelman owns 2,596,387 shares of Applied Therapeutics stock worth more than $6,958,317 as of January 10th. This net worth evaluation does not reflect any other investments that Dr. Shendelman may own. Additionally, Dr. Shendelman receives an annual salary of $813,470.00 as CEO at Applied Therapeutics. Learn More about …Complete Applied Therapeutics Inc. stock information by Barron's. View real-time APLT stock price and news, along with industry-best analysis.NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced it has entered into a definitive securities purchase …Applied Therapeutics Inc (NASDAQ: APLT) released topline results of the ARISE-HF Phase 3 trial of AT-001 (caficrestat) in patients with Diabetic Cardiomyopathy (DbCM) at high risk ofJan 5, 2024 ... Applied Therapeutics shares dipped 35.6% to $2.4498 on Friday. Here are some other stocks moving in today's mid-day session. Gainers. Ainos, Inc ...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past...Our mission is to create transformative treatments for patients with high unmet need conditions. Applied Therapeutics uses technological advances and abbreviated regulatory pathways, wherever possible, to design treatments for indications with significant unmet medical need. By taking a unique and focused approach, the company can significantly ... The Applied Therapeutics stock forecast for tomorrow is $ 5.29, which would represent a -1.61% loss compared to the current price. In the next week, the price of APLT is expected to decrease by -17.44% and hit $ 4.44.. As far as the long-term Applied Therapeutics stock forecast is concerned, here’s what our predictions are currently …Feb 2, 2024 · With Applied Therapeutics stock trading at $3.12 per share, the total value of Applied Therapeutics stock (market capitalization) is $240.96M. Applied Therapeutics stock was originally listed at a price of $9.40 in May 14, 2019. If you had invested in Applied Therapeutics stock at $9.40, your return over the last 4 years would have been -66.81% ... Applied Therapeutics, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 03828A101 (CUSIP Number) 2/9/2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ...It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. The VGM score is based on the trading styles of ...Applied Therapeutics Stock Forecast. All Analysts Top Analysts Stock Price Forecast. The 2 analysts with 12-month price forecasts for APLT stock have an average target of 10.5, with a low estimate of 7.00 and a high estimate of 14. The average target predicts an increase of 95.17% from the current stock price of 5.38.Applied Therapeutics Announces Full Enrollment in the Registrational Phase 3 ARISE-HF Trial of AT-001 in Diabetic Cardiomyopathy. (GlobeNewswire) +6.91%. Oct-09-22 09:13AM. Insiders who purchased Applied Therapeutics, Inc. (NASDAQ:APLT) earlier this year lose an additional US$86k as the stock sinks to US$0.62. (Simply Wall St.) Jan 23, 2024 · Applied Therapeutics Inc (APLT) stock is trading at $2.84 as of 1:05 PM on Tuesday, Jan 23, a rise of $0.09, or 3.09% from the previous closing price of $2.75. The stock has traded between $2.76 and $3.02 so far today. Volume today is light. NEW YORK, Jan. 21, 2020 -- Applied Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications...Jul 6, 2020 ... The short attack, pulling no punches, says: “We believe that Applied Therapeutics' stock is wildly overvalued and that its prospects for ...Applied Therapeutics Inc (ZB_58319995.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Applied Therapeutics Inc | Nasdaq ... Feb 15, 2024 · Applied Therapeutics stock has received a consensus rating of buy. The average rating score is and is based on 4 buy ratings, 2 hold ratings, and 0 sell ratings. What was the 52-week low for ... Applied Therapeutics (APLT) stock hit a new 52-week high as data from the biotech's Phase 3 INSPIRE trial for lead drug continued to impress investors. Read more here.Aldose Reductase is an enzyme involved in the pathophysiology of numerous diseases with high unmet medical need. Applied Therapeutics has developed a new generation of ARIs that have been developed for conditions such as Galactosemia and Diabetic Cardiomyopathy. Utilizing advanced crystallography , the company has developed a …Applied Therapeutics Announces Topline Results from the ARISE-HF Phase 3 Study of AT-001 in Diabetic Cardiomyopathy. AT-001 (caficrestat) demonstrated a strong trend in stabilizing cardiac functional capacity, while the placebo group declined over 15 months AT-001 treatment resulted in a statistically significant difference in cardiac functional capacity in a prespecified subgroup of patients ... In today’s fast-paced world, finding activities that provide relaxation and a sense of accomplishment is more important than ever. One such activity that has gained popularity in r...Results of Applied Therapeutics' Phase 3 INSPIRE trial for oral govorestat (AT-007). Govorestat demonstrates significant sorbitol reduction, improving mobility and overall well-being in SORD ...Applied Therapeutics (APLT) stock hit a new 52-week high as data from the biotech's Phase 3 INSPIRE trial for lead drug continued to impress investors. Read more here.Why Is Applied Therapeutics (APLT) Stock Down 30% Today? InvestorPlace 21d. Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket. Benzinga 21d.Feb 15, 2024 · Applied Therapeutics Inc APLT shares are trading higher after the company, on Thursday, released interim 12-month results from the ongoing Phase 3 INSPIRE trial, in which the primary and several ... Citigroup increased their target price on Applied Therapeutics from $5.00 to $7.00 and gave the stock a buy rating in a research report on Friday, February 16th.Applied Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. APLT updated stock price target summary. Applied Therapeutics, Inc. est une société biopharmaceutique au stade clinique. La société se concentre sur le développement d'un portefeuille de produits ...What is the Applied Therapeutics stock forecast? · Applied Therapeutics stock prediction for 1 year from now: $ 33.91 (505.48%) · Applied Therapeutics stock ...Applied Therapeutics (APLT) Stock Price, News & Analysis. $5.38. +1.63 (+43.47%) (As of 04:26 PM ET) Compare. Today's Range. $3.73. . $5.83. 50-Day …Applied Therapeutics (APLT) sotck rises as its late-stage trial for lead asset govorestat hits main goals in Sorbitol Dehydrogenase ((SORD)) Deficiency. Read more here.Find out the direct holders, institutional holders and mutual fund holders for Applied Therapeutics, Inc. (APLT).Stock Quote & Chart | Applied Therapeutics. Change. Volume. Today's Open. Previous Close. Today's High. Today's Low. 52 Week High. 52 Week Low. Stock Chart. EGRX. …Applied Therapeutics Inc. Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New …Why Is Applied Therapeutics (APLT) Stock Down 30% Today? Benzinga 34d. Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket. InvestorPlace 34d.The more transactions an expert has, the more significant the results become. 1. Denali Therapeutics. Markets Insider. Ticker: DNLI. Market cap: $2.49B. …Applied Therapeutics, Inc. (APLT) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. 2W 10W 9M. 5.63 +0.03 (+0.54%) As of 09:34AM EST. Market open. 1d. Long-term APLT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050. Our analysts are offering long term price forecasts for Applied Therapeutics Inc In 2050, the median target price for APLT is $ 2.8103, with a high estimate of $ 32.08 and a low estimate of $ 0.1441. The median estimate represents a -50.08% decrease from the last price of ...It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. The VGM score is based on the trading styles of ...Apr 24, 2023 ... NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. ... The Private Placement was led by new investor Venrock Healthcare ...Applied Therapeutics Inc. Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New …Currently, Applied Therapeutics stock is climbing 16.04 percent, to $3.11 over the previous close of $2.68 on a volume of 3,752,156. It had traded between $0.757 and $4.42 for the past 52 weeks on ...78.27. +0.09(+0.12%) Gold. 2,035.50. -4.30(-0.21%) Applied Therapeutics, Inc. (APLT) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. 2W 10W 9M. 5.31 -0.07 (-1.30%) At close:...Feb 16, 2024 · Applied Therapeutics' phase 3 INSPIRE study using govorestat for treatment of patients with SORD deficiency achieved. Read why I rate APLT stock a buy. NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced results from the ACTION-Galactosemia Kids study of govorestat (AT …APLT's cash and cash equivalents stood at $37.457 million as of September 30, 2023. Warning! GuruFocus has detected 6 Warning Signs with APLT. On November 9, 2023, Applied Therapeutics Inc ...2 days ago · The latest price target for Applied Therapeutics ( NASDAQ: APLT) was reported by Baird on Tuesday, April 25, 2023. The analyst firm set a price target for 14.00 expecting APLT to rise to within 12 ... Jan 4, 2024 · NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated ... Feb 15, 2024 ... Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular ...Applied Therapeutics Inc. analyst ratings, historical stock prices, ... Actuals & Estimates Applied Therapeutics Inc. Quarterly; Annual; Actual Analyst Range Consensus. 0.20 0.00-0.20-0.40. Actual ...In 2030, the Applied Therapeutics stock will reach $ 73.38 if it maintains its current 10-year average growth rate. If this Applied Therapeutics stock prediction for 2030 materializes, APLT stock willgrow 2,539.43% from its current price. Feb 2, 2024 · With Applied Therapeutics stock trading at $3.12 per share, the total value of Applied Therapeutics stock (market capitalization) is $240.96M. Applied Therapeutics stock was originally listed at a price of $9.40 in May 14, 2019. If you had invested in Applied Therapeutics stock at $9.40, your return over the last 4 years would have been -66.81% ... NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced it has entered into a definitive securities purchase …
Information on stock, financials, earnings, subsidiaries, investors, and executives for Applied Therapeutics. Use the PitchBook Platform to explore the full .... Blue care network michigan
Real time Applied Therapeutics (APLT) stock price quote, stock ... Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel ... As we age, it’s important to keep our minds sharp and engaged. One way to do this is by participating in crossword puzzles. Not only are they a fun and enjoyable activity, but they...Fintel reports that on February 22, 2024, Leerink Partners initiated coverage of Applied Therapeutics (NasdaqGM:APLT) with a Outperform recommendation. Analyst Price Forecast Suggests 52.44% ...Shares of Applied Therapeutics ( APLT 2.50%), a clinical-stage biopharmaceutical company, are sliding today in response to upsetting news regarding its lead candidate. It turns out the Food and ...Find the latest Applied Therapeutics, Inc. (APLT) stock quote, history, news and other vital information to help you with your stock trading and investing.Applied Therapeutics stock is tumbling on Friday as investors react to lackluster results from a Phase 3 clinical trial of AT-001.More From InvestorPlace The #1 AI Investment Might Be This Company ...The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestig...Company profile page for Applied Therapeutics Inc including stock price, company news, executives, ... Applied Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company.Applied Therapeutics (NASDAQ:APLT) stock is falling on Friday following the release of Phase 3 clinical trial data from the clinical-stage biopharmaceutical company.Applied Therapeutics (APLT) News Today. $2.68. -0.04 (-1.47%) (As of 02/14/2024 ET) Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media Sustainability. Source. Sentiment All Sentiments. Source. Headline.Feb 15, 2024 ... Currently, Applied Therapeutics stock is climbing 16.04 percent, to $3.11 over the previous close of $2.68 on a volume of 3,752,156. It had ...NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stoc....
Popular Topics
Heb locations near me | Bears are Losing Control Over Applied Therapeutics Inc. (APLT), Here's Why It's a 'Buy' Now Zacks - Fri Sep 2, 2022 . After losing some value lately, a hammer chart pattern has been formed for Applied Therapeutics Inc. (APLT), indicating that the stock has found support. This, combined with an upward trend in earnings...NEW YORK, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated ......
Twilight laurent | Applied Therapeutics, Inc. est une société biopharmaceutique au stade clinique. La société se concentre sur le développement d'un portefeuille de produits ...A 6% change in cardiac functional capacity has been shown to predict long-term survival and hospitalization for heart failure. The effect of AT-001 was dose-dependent, with the low dose (1000mg ......
Cryptocars | Results of Applied Therapeutics' Phase 3 INSPIRE trial for oral govorestat (AT-007). Govorestat demonstrates significant sorbitol reduction, improving mobility and overall well-being in SORD ...Track Applied Therapeutics Inc (APLT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAs we age, it’s important to keep our minds sharp and engaged. One way to do this is by participating in crossword puzzles. Not only are they a fun and enjoyable activity, but they......
Sofia reyes | Applied Therapeutics gains after regulatory update on lead asset Sep. 06, 2023 9:17 AM ET Applied Therapeutics, Inc. (APLT) Stock By: Dulan Lokuwithana , SA News Editor GrandbrothersApplied Therapeutics-stock. Applied Therapeutics Inc Registered Shs Stock , APLT. 2.99 -0.03 -1.02% 03:21:32 PM. NAS. Add to watchlist. News. Analyst …NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated ......
Nobody gets me | As we age, it’s important to keep our minds sharp and engaged. One way to do this is by participating in crossword puzzles. Not only are they a fun and enjoyable activity, but they...Applied Therapeutics. APLT. $5.60 ... as of February 22 4:00:00 PM EST. Applied Therapeutics (APLT) Stock Price Performance. Applied Therapeutics (APLT) Stock Key Data. Summary Additional Data ... APLT - Applied Therapeutics Inc Stock Price and Quote. Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. APLT. Applied …...
Turo near me | Fintel reports that on February 22, 2024, Leerink Partners initiated coverage of Applied Therapeutics (NasdaqGM:APLT) with a Outperform recommendation. Analyst Price Forecast Suggests 52.44% ...Applied Therapeutics (APLT) News Today. $2.68. -0.04 (-1.47%) (As of 02/14/2024 ET) Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media Sustainability. Source. Sentiment All Sentiments. Source. Headline....